Skip to main content

Biologic alternatives to stents and grafts

Current Cardiology Reports volume 3, pages 17–21 (2001)Cite this article

Abstract

The quest for biologic alternatives to stents and arterial grafts is a source of intense research at the basic and preclinical level. Several new devices and conduits currently under investigation may extend the uses of both stents and grafts beyond their current revascularization role into newer applications in the fields of regional pharmacology and gene therapy. This exciting prospect, although still unrealized, has general medical implications beyond cardiovascular disease. Development of such synergies between device, grafts, pharmacologic, molecular, and tissue engineering research is essential if the burgeoning data on new therapeutic genes is to be harnessed for clinical benefit.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References and Recommended Reading

  1. Alt E, Haehnel I, Beilharz C, et al.: Inhibition of neointima formation after experimental coronary artery stenting; a new biodegradable stent coating releasing hirudin and the prostacyclin analogue Iloprost. Circulation 2000, 101:1453–1458. This study showed feasibility of using polymers on stents as a drug delivery system.

    PubMed  CAS  Google Scholar 

  2. Bertrand O, Sipehia R, Mongrain R, et al.: Biocompatibility aspects of new stent technology. J Am Coll Cardiol 1998, 32:562–571. This study showed feasibility of using polymers on stents as a drug delivery system.

    PubMed  Article  CAS  Google Scholar 

  3. Blindt R, Hoffmeister K, Bienert H, et al.: Development of anew biodegradable intravascualr polymer stent with simultaneous incorporation of bioactive substances. Intl J Artific Organs 1999, 22:843–853.

    CAS  Google Scholar 

  4. Hermann R, Schmidmaier G, Markl B, et al.: Anti-thrombotic coating of stents using a biodegradable drug delivery technology. Thromb Haemost 1999, 82:51–57.

    Google Scholar 

  5. Yamawaki T, Shimokawa H, Kozai T, et al.: Intramural delivery of aspecific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo. J Am Coll Cardiol 1998, 32:780–786.

    PubMed  Article  CAS  Google Scholar 

  6. Stefanadis C, Toutouzas P: Percutaneous implantation of autologous vein graft stent for treatment of coronary artery disease. Lancet 1995, 345:1509.

    PubMed  Article  CAS  Google Scholar 

  7. Makutani S, Kichikawa K, Uchida H, et al.: Effect of antithrombotic agents on the patency of PTFE-covered stents in the inferior vena cava; dan experimental study. Cardiovasc Intervent Radiol 1999, 22:232–238.

    PubMed  Article  CAS  Google Scholar 

  8. Mc Kenna C, Camrud A, Sangiorgi G, et al.: Fibrin-film stenting in a porcine coronary injury model: efficacy and safety compared to uncoated stents. J Am Coll Cardiol 1998, 31:1434–1438.

    Article  Google Scholar 

  9. Stefanadis C, Toutouzas K, Tsiamis E, et al.: Implantation of stents covered by autologous arterial grafts in human coronary arteries; a new technique. J Invas Cardiol 2000, 12:7–10.

    CAS  Google Scholar 

  10. Willard J, Landau C, Glamann D, et al.: Genetic modification of the vessel wall: comparison of surgical and catheter-based techniques for delivery of recombinant adenovirus. Circulation 1994, 89:2190–2197.

    PubMed  CAS  Google Scholar 

  11. Clowes A: Vascular gene therapy in the 21st century. Thromb Haemost 1997, 78:605–610.

    PubMed  CAS  Google Scholar 

  12. Dichek D, Nussbaum O, Degen S, Anderson W: Enhancement of the fibrinolytic activity of sheep endothelial cells by retroviral vector-mediated gene transfer. Blood 1991, 77:533–541.

    PubMed  CAS  Google Scholar 

  13. Flugelman M, Virmani R, Leon M, et al.: Genetically engineered endotheial cells remain adherent and viable after stent deployment and exposure to flow in vitro. Circulation Research 1992, 70:348–354.

    PubMed  CAS  Google Scholar 

  14. Wilson J, Birinyi L, Salomon R, et al.: Implantation of vascular grafts lined with genetically modified endothelial cells. Science 1989, 244:1344–1346.

    PubMed  Article  CAS  Google Scholar 

  15. Conte M, Birinyi L, Miyata T, et al.: Efficient repopulation of denuded rabbit arteries with autologous genetically modified endothelial cells. Circulation 1994, 23:2161–2169.

    Google Scholar 

  16. Fischlein T, Zilla P, Meinhart J, et al.: In vitro endothelialization of a mesosystemic shunt: a clinical case report. J Vascular Surgery 1994, 19:549–554.

    CAS  Google Scholar 

  17. Zilla P, Deutsch M, Meinhart J, et al.: Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years. J Vasc Surg 1994, 19:540–548.

    PubMed  CAS  Google Scholar 

  18. Plautz G, Nabel E, Nabel G: Introduction of vascular smooth muscle cells expressing recombinant genes in vivo. Circulation 1991, 83:578–583.

    PubMed  CAS  Google Scholar 

  19. Heart and Stroke Facts. Statistical Supplement. American Heart Association: Dallas, TX; 1996.

  20. Herring M, Gardner A, Glover J: A single stage technique for seeding vascular grafts with autogenous endothelium. Surgery 1987, 84:498–502.

    Google Scholar 

  21. Williams S, Jarrell B, Kleinert L: Endothelial cell transplantation onto porcine arteriovenous grafts evaluated using a canine model. J Invest Surg 1994, 7:503–517.

    PubMed  CAS  Google Scholar 

  22. Pasic M: Superior late patency of small diameter Dacron grafts seeded with omental microvascualar cells; an experimental study. Ann Thorac Surg 1994, 58:677–682.

    PubMed  CAS  Article  Google Scholar 

  23. Bowlin G, Rittgers S: Electrostatic endothelial cell seeding technique for small diameter vascular prostheses: feasibility testing. Cell Transplant 1999, 6:623–629.

    Article  Google Scholar 

  24. Weinberg C, Bell E: A blood vessel model constructed from collagen and cultured vascular cells. Science 1986, 231:397–399.

    PubMed  Article  CAS  Google Scholar 

  25. Matsuda T, Miwa H: A hybrid vascular model biomimicking the hierarchic structure of the arterial wall. J Thorac Cardiovasc Surg 1995, 110:988–997.

    PubMed  Article  CAS  Google Scholar 

  26. Ziegler T, Robinson K, Alexander R, Nerem R: Co-culture of endothelial and smooth muscle cells in a flow environment; an improved culture model of the vascular wall? Cell Mater 1995, 5:115–124.

    Google Scholar 

  27. Tranquillo R, Girton T, Bromberek B, et al.: Magnetically oriented tissue-equivalent tubes. Biomaterials 1996, 17:349–353.

    PubMed  Article  CAS  Google Scholar 

  28. L’Heureux N, Paquet S, Germain L, et al.: A completely biological tissue engineered human blood vessel. FASEB J 1998, 12:47–56.

    PubMed  CAS  Google Scholar 

  29. Niklason L, Gao J, Abbott W, et al.: Functional arteries grown in vitro. Science 1999, 284:489–493.

    PubMed  Article  CAS  Google Scholar 

  30. Conte M: The ideal small arterial substitute: a search for the holy grail. FASEB J 1998, 12:43–45.

    PubMed  CAS  Google Scholar 

  31. Veelken H, Jesuiter H, Mackensen A, et al.: Primary fibroblasts from human adults as target cells for ex vivo transfection and gene therapy. Hum Gene Ther 1994, 5:1203–1210.

    PubMed  CAS  Google Scholar 

  32. Geary R, Clowes A, Lau S, et al.: Gene transfer in baboons using prosthetic vascular grafts seeded with retrovirally transduced smooth muscle cells: a model for local and systemic gene therapy. Hum Gene Ther 1994, 5:1211–1216.

    PubMed  CAS  Google Scholar 

  33. Huynh T, Abraham G, Murray J, et al.: Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nat Biotechnol 1999, 17:1083–1086. This study showed feasibility of using polymers on stents as a drug delivery system.

    PubMed  Article  CAS  Google Scholar 

  34. Ziegler T, Nerem RM: Tissue engineering of a blood vessel: regulation of vascular biology by mechanical stress. J Cell Biochem 1994, 56:204–209.

    PubMed  Article  CAS  Google Scholar 

  35. Campbell J, Efendy J, Campbell G: Novel vascular graft grown within recipient’s own peritoneal cavity. Circ Res 1999, 85:1173–1178. This was one of the first attempts to grow vascular cells onto a stent for use in vascular gene therapy.

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Division of Cardiovascular Diseases & Molecular Medicine Program, Mayo Clinic, 200 First Street SW, 55905, Rochester, MN, USA

    Noel M. Caplice MD, PhD

Authors
  1. Noel M. Caplice MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Caplice, N.M. Biologic alternatives to stents and grafts. Curr Cardiol Rep 3, 17–21 (2001). https://doi.org/10.1007/s11886-001-0005-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-001-0005-1

Keywords

  • Iloprost
  • Intimal Hyperplasia
  • Vascular Graft
  • Chronic Total Occlusion
  • Arterial Graft